Marta
López Sánchez
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitari de Bellvitge (14)
2022
-
Patient-reported outcomes measures (PROMs) and patient-reported experience measures (PREMs) of COVID-19 telerehabilitation: Prospective pilot program
Medicine (United States), Vol. 101, Núm. 31, pp. E29639
-
Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units
Medicina Intensiva, Vol. 46, Núm. 2, pp. 81-89
2019
-
Imbalance in the Expression of Genes Associated with Purinergic Signalling in the Lung and Systemic Arteries of COPD Patients
Scientific Reports, Vol. 9, Núm. 1
2018
-
Defining the role of neutrophil-to-lymphocyte ratio in COPD: A systematic literature review
International Journal of COPD, Vol. 13, pp. 3651-3662
-
Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients
International Journal of COPD, Vol. 13, pp. 141-148
-
Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD
Respiratory Research, Vol. 19, Núm. 1
2017
-
Effectiveness of a Respiratory Day Hospital Program to Reduce Admissions for Exacerbation in Patients with Severe COPD: A Prospective, Multicenter Study
COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 14, Núm. 3, pp. 304-310
-
Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine)
PLoS ONE, Vol. 12, Núm. 5
2016
-
Systemic and pulmonary vascular remodelling in chronic obstructive pulmonary disease
PLoS ONE, Vol. 11, Núm. 4
-
Treatment of patients with COPD and recurrent exacerbations: The role of infection and inflammation
International Journal of COPD, Vol. 11, Núm. 1, pp. 515-525
2015
-
Gene and Protein Expression of Fibronectin and Tenascin-C in Lung Samples from COPD Patients
Lung, Vol. 193, Núm. 3, pp. 335-343
-
Roflumilast added to triple therapy in patients with severe COPD: A real life study
Pulmonary Pharmacology and Therapeutics, Vol. 30, pp. 16-21